According to 4D Molecular Therapeutics's latest financial reports the company's current revenue (TTM) is NZ$32.67 M. In 2023 the company made a revenue of NZ$32.76 M an increase over the revenue in the year 2022 that were of NZ$4.92 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.